Neo Ivy Capital Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $882K | Buy |
+4,910
| New | +$882K | 0.28% | 130 |
|
|
2025
Q1 | – | Sell |
-24,681
| Closed | -$3.72M | – | 320 |
|
|
2024
Q4 | $3.72M | Buy |
+24,681
| New | +$3.72M | 0.75% | 32 |
|
|
2023
Q4 | – | Sell |
-5,404
| Closed | -$659K | – | 334 |
|
|
2023
Q3 | $659K | Buy |
+5,404
| New | +$659K | 0.29% | 112 |
|
|
2022
Q4 | – | Sell |
-20
| Closed | -$2K | – | 388 |
|
|
2022
Q3 | $2K | Buy |
+20
| New | +$2K | 0.01% | 358 |
|
|
2022
Q2 | – | Sell |
-462
| Closed | -$64K | – | 454 |
|
|
2022
Q1 | $64K | Buy |
462
+303
| +191% | +$42K | 0.06% | 353 |
|
|
2021
Q4 | $28K | Sell |
159
-1,037
| -87% | -$183K | 0.04% | 339 |
|
|
2021
Q3 | $136K | Buy |
+1,196
| New | +$136K | 0.16% | 201 |
|
|
2021
Q2 | – | Sell |
-44
| Closed | -$6K | – | 487 |
|
|
2021
Q1 | $6K | Sell |
44
-4,871
| -99% | -$664K | 0.01% | 431 |
|
|
2020
Q4 | $586K | Buy |
4,915
+4,713
| +2,333% | +$562K | 0.65% | 38 |
|
|
2020
Q3 | $23K | Sell |
202
-994
| -83% | -$113K | 0.02% | 406 |
|
|
2020
Q2 | $136K | Sell |
1,196
-753
| -39% | -$85.6K | 0.16% | 201 |
|
|
2020
Q1 | $157K | Buy |
+1,949
| New | +$157K | 0.26% | 157 |
|
|
2019
Q3 | – | Sell |
-1,855
| Closed | -$189K | – | 310 |
|
|
2019
Q2 | $189K | Buy |
+1,855
| New | +$189K | 0.11% | 209 |
|